ARCE Therapeutics, also known as 承寶生技股份有限公司, is a leading brand in the field of genetic-engineered cellular immunotherapy. Our focus is on developing cutting-edge treatments for a range of malignancies, including both hematological and solid tumors, as well as non-cancer diseases. With a dedicated team of experts, we specialize in chimeric antigen receptor T cell therapy (CAR-T), which holds tremendous potential in revolutionizing the way we combat diseases.

At ARCE Therapeutics, we are committed to creating state-of-the-art products of new generation CAR-T cell therapy that are highly potent, safe, and durable. Our ultimate goal is to achieve sustained improved responses that can conquer human diseases. We prioritize the needs of patients and strive to provide effective treatments at a reasonable cost through our innovative immune cell therapy approach.

Collaboration is at the heart of our work. We partner with leading organizations worldwide to combine various technologies and platforms, aiming to shorten the manufacturing process of CAR-T and expand its administration from autologous to allogeneic, benefiting a larger number of patients. With a senior management team and board of directors boasting extensive experience in scientific research, business leadership, and the biotech industry, we are well-equipped to drive advancements in drug discovery and development.

Our expertise spans clinical trials, regulatory affairs, business development, and intellectual property management. To learn more about our groundbreaking work and discuss potential collaborations, please email us at contact@arcetherapeutics. com or call us at 886-2-26581868.

Together, let's shape the future of cellular immunotherapy